Are You Managing a Stem Cell Company or Cord Blood Bank?
We can assist you with your strategic goals, because we specialize in your industry niche. BioInformant is the only company that has specifically tracked the stem cell sector since it emerged.
Because there are hematopoietic stem cells in cord blood and mesenchymal stem cells in cord tissue, we’ve also been tracking the cord blood industry since 2006.
Our leadership team comes from a bioinformatics background – the science of collecting and analyzing complex biological data such as genetic codes – and we’re trained in applying these novel data analysis techniques to the field of market research.
To date, BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CBS News, the California Institute of Regenerative Medicine (CIRM), and more.
Only Research Firm that Has Served the Stem Cell Market Since It Emerged
Our focus on the stem cell industry and our historical knowledge of it makes us uniquely positioned to be your source of market information.
We began tracking the stem cell industry in 2004 when only two types of stem cells were commonly discussed, adult stem cells and embryonic stem cells.
Today, researchers debate the number of stem cells in existence, as the number depends on whether stem cells are characterized functionally (e.g. neural stem cells, mesenchymal stem cells, induced pluripotent stem cells) or characterized by source tissue (e.g cord blood stem cells, dental pulp stem cells, amniotic stem cells, etc.).
What is clear is that dozens of stem cell types now exist, all representing unique opportunities for your company.
Serving Leading Biotech & Pharma Companies Worldwide
For executives operating a stem cell company or cord blood bank, competing in the marketplace is a difficult task. You must analyze market conditions, predict industry trends, and capitalize on market changes before the competition. Especially within the rapidly evolving stem cell marketplace, it can be difficult to make educated, informed decisions that produce revenue growth for your company, while limiting failed products that won’t have demand in the marketplace.
Some stem cell companies and cord blood banks make expensive new hires or elect to maintain costly business development departments in an effort to compete. For a much smaller investment, you can immediately make informed, educated decisions about your marketplace.
When you are operating every day, you are living within a small micro-environment: your company. Therefore, you can’t easily see the changes and shifting trends that are talking place in the larger macro-environment: your marketplace. Market intelligence is the small “lever” that can create big results for your company.
Because we are dedicated exclusively to stem cell markets, we understand current and future product trends more intimately than any other company. To date, we have served most of the world’s leading stem cell companies and organizations.
Cord Blood is Richly Populated with Stem Cells
There are hematopoietic stem cells in cord blood and mesenchymal stem cells in cord tissue. There are also progenitor cells in both placental tissue and amniotic tissues. As such, we have also have been tracking the cord blood banking industry since 2006 and are the leading cord blood research firm worldwide. To date, we have served nearly all of the world’s leading cord blood banks.
Your Trusted Provider of Stem Cell Industry Data
To date, BioInformant has been featured on prominent news outlets that include the Wall Street Journal, Nature Biotechnology, Medical Ethics, CBS News, the California Institute for Regenerative Medicine, the Center for Commercialization of Regenerative Medicine, and more.
We also attended the annual World Cord Blood Conference (Boston, MA) as a strategic partner of the organizer, are assisting with the World Cord Blood Congress Europe (London, UK), are presenting stem cell market data at the virtual conference StemCell MeetUp, and have been featured as a “Publisher Spotlight” on MarketResearch.com, among many other initiatives.
Importantly, we have also partnered with the Save the Cord Foundation, a 501(c)(3) non-profit dedicated to cord blood banking awareness and education, to run an awareness campaign called “Cord Blood Banking Awareness: Educating America and the World.” Learn more about the initiative here: http://www.bioinformant.com/save-the-cord-foundation-and-bioinformant-join-forces-in-global-effort-to-increase-cord-blood-banking-awareness/.
We enjoy connecting with our clients at stem cell and cord blood industry conferences worldwide.
U.S. Based Company with Headquarters in Roseville, MN, and Washington, DC
As a U.S. based company, we are available to meet and speak with you about your questions. Having direct contact with you allows us to clearly understand your core objectives, which are to:
- Make smarter decisions, faster
- Compete without the expense of new hires or a huge business development department
- Assess profitable opportunities within stem cell or cord blood markets
- Develop high-demand products that will bring customers to you, instead of your competition
- Increase revenue within your organization
- Minimize risk by understanding competitive threats
We track the stem cell industry continuously in real-time, so we have a unique ability to connect with about your market strengths, weaknesses, opportunities, and threats.
Currently, we are the only provider of stem cell market research offering direct support and engagement as a complimentary service.
Providing You with FREE Stem Cell and Cord Blood Market Insights
We also publish a huge amount of FREE content about market trends and opportunities at our blog.
Because stem cell science is rapidly evolving, there are constant events in the sector that shift industry dynamics. Often, these events are announcements of technical or scientific advancements. Sometimes they are announcements of major industry alliances. Occasionally, they are announcements of a new industry competitor, a major milestone, or a significant funding award.
For those of us interested in stem cell and cord blood markets, tracking these shifting dynamics is of paramount importance. We also publish current trend rate data so that you can immediately make more informed, educated decisions about the direction your company.
View the BioInformant blog now.
You don’t have to take our word for it, because our clients say it best:
60-Day Money Back Guarantee To Ensure Your Satisfaction
Finally, all BioInformant products come with a 100% Money Back Guarantee. If the strategies and tools aren’t helpful to you – we’ll cheerfully refund your money, and you can keep the product.
When you purchase stem cell or cord blood market intelligence from us, you aren’t just purchasing your product. You are purchasing access to our elite team of stem cell experts, headed by our President/CEO, Cade Hildreth, a stem cell expert and autologous stem cell transplant recipient.
View BioInformant’s global strategic reports for the stem cell industry now.